FDA Alerts

The FDA recently approved a new oral Janus kinase inhibitor for the treatment of adult patients with moderate to severe active rheumatoid arthritis.

The US Food and Drug Administration has approved a new once-daily oral tablet for the treatment of osteoarthritis pain. The drug also contains a built-in antihypertensive.

The US Food and Drug Administration has approved the expansion of the indication of tofacitinib to include some adults with ulcerative colitis, making it the first oral medication approved for chronic use...

The US Food and Drug Administration has approved a new product for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause.

The US Food and Drug Administration has approved expanding the label of a psoriasis drug to include adults with moderate-to-severe plaque psoriasis.

The US Food and Drug Administration has approved a subcutaneous injection for the treatment of a rare and serious genetic disease involving the inability to break down phenylananine.

See what hematology news your colleagues have been reading.

The FDA has approved a label update for a biologic used for the treatment of adult patients with moderate-to-severe plaque psoriasis

The US Food and Drug Administration has approved a fifth indication for a human monoclonal antibody commonly used for the treatment of osteoporosis.

The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.